Anti-DR5 IgM antibody(IGM Biosciences)

N/A

Report date: 2023/12/11 18:14:03

Base Information

Drug NameAnti-DR5 IgM antibody(IGM Biosciences)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionTumor necrosis factor receptor superfamily member 10B agonists

TargetsTumor necrosis factor receptor superfamily member 10B

Therapy Area/IndicationsSolid tumoursHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesIgm Biosciences Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSolid tumoursHematologic Neoplasms

Inactive IndicationsN/A

ATC CodeN/A